MOBILion Systems Unveils Groundbreaking Advances in Proteomics
MOBILion Systems, Inc., known for its leadership in separation science, is set to make a significant impact at the upcoming HUPO World Congress, where they will showcase their revolutionary PAMAF™ technology. This innovative approach brings remarkable advancements in mass spectrometry, enhancing sensitivity and throughput for the field of proteomics.
The Power of PAMAF™ Technology
PAMAF™ technology stands out by achieving near-complete ion utilization, which allows for deeper exploration of the proteome. This technique is designed to significantly improve the analysis of post-translational modifications (PTMs) and proteoforms, making it essential for scientists focusing on drug development and clinical diagnostics.
Enhanced Detection Capabilities
As research in proteomics evolves, the need for technologies that augment detection depth becomes critical. MOBILion's PAMAF technology meets this demand with exceptional spectral generation rates, exceeding 500Hz. This advancement is made possible by the company’s high-speed HRIM separation, which minimizes dependence on conventional quadrupole filtering methods that can be slow and lossy.
Remarkable Gains in Sensitivity
According to Melissa Sherman, Ph.D., CEO of MOBILion Systems, PAMAF technology offers unprecedented improvements in fragment ion intensity, with increases ranging from 300 to 2,000%. These advancements empower researchers to detect a broader array of proteins and PTMs, even from smaller sample sizes. This could open entirely new avenues in proteomics, biomarker discovery, and therapeutic development.
Research Data and Future Implications
The details of the findings that will be presented by Chief Technology Officer Daniel DeBord are astounding. The experiments conducted in collaboration with existing QTOF platforms demonstrated a staggering increase in fragment ion intensity—up to 100-fold increases were observed, along with 3 to 12 times more protein groups identified. These enhancements translate into 43 to 53% higher peptide counts per protein, particularly at low sample inputs.
Transformational Impact on Single-Cell Proteomics
MOBILion's PAMAF operation mode is not just an improvement; it's transformative for single-cell proteomics and quantitative PTM measurements. By enhancing ion utilization and aligning fragmentation with ion mobility, PAMAF enables a more comprehensive and unbiased analysis of complex biological samples.
About MOBILion Systems, Inc.
MOBILion Systems is dedicated to developing high-performance analytical instruments that allow researchers to uncover previously invisible molecular details. By combining Structures for Lossless Ion Manipulation (SLIM) technology with high-resolution mass spectrometry, MOBILion enhances separation power, sensitivity, and throughput. The company’s mission centers on empowering scientists to accelerate discoveries and advance precision medicine, ultimately leading to improved health outcomes.
Frequently Asked Questions
What is PAMAF™ technology?
PAMAF™ technology enables near-complete ion utilization and enhanced sensitivity in mass spectrometry for proteomics.
How does MOBILion improve mass spectrometry?
MOBILion's high-speed HRIM separation reduces reliance on quadrupole filtering, resulting in faster and more efficient analyses.
What improvements does PAMAF offer for researchers?
Researchers using PAMAF can see increases in fragment ion intensity and identification rates, significantly boosting their ability to detect proteins and PTMs.
What are the implications for single-cell proteomics?
The technology’s enhancements through PAMAF are set to revolutionize single-cell proteomics and quantitative PTM measurements.
How does MOBILion contribute to scientific discovery?
The company's innovative instruments and technologies aim to advance research in areas like proteomics, metabolomics, and clinical studies, ultimately benefiting precision medicine.
